[ Price : $8.95]
FDA releases an FDA-483 with five observations from an inspection at STAQ Pharma.[ Price : $8.95]
FDA and the generic drug industry each offer proposals to advance quicker ANDA approvals.[ Price : $8.95]
Researchers say there is a correlation between medical device company payments to doctors and the selection of defibrillator devic...[ Price : $8.95]
Bristol Myers Squibb announces positive results from POETYK PSO-1, a pivotal Phase 3 trial evaluating deucravacitinib, a novel, or...[ Price : $8.95]
Three stakeholders comment on an FDA draft guidance on using patient-reported outcomes in evaluating medical products.[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension for Generic Clearance for the Collection of Qualitat...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension for Exceptions or Alternatives to Labeling Requireme...[ Price : $8.95]
FDA warns Cosmax USA about CGMP violations in its production of finished drugs.